Eli Lilly CEO: Speed and industry cooperation are aiding coronavirus treatment development
Eli Lilly CEO Dave Ricks told CNBC on Monday the pharmaceutical industry’s pursuit of treatments and vaccines for the coronavirus pandemic has been defined by two qualities: speed and cooperation.
“Speed is a hallmark to the industry’s response to Covid-19, and I don’t think most everyday listeners understand. We developed this antibody and got to proof of concept in six months,” Ricks said in an interview with CNBC’s Jim Cramer. “Usually, that’s more than six years.”
The global health crisis also brought together industry rivals in hopes of accelerating the development — and the production — of drugs that may help limit the impact of Covid-19, Ricks said. More than 31.1 million people worldwide have been infected and at least 962,343 have died …continued .
[Source: CNBC News]